Background: The aim of this pilot investigation was to see if a raised serum S100B level or a decrease in rSO2 following carotid revascularization with CEA might be used to detect neurological instability in CEA patients. Increased serum S100B levels during CEA, we hypothesized, would be linked to neurological symptoms after surgery. Patients and methods: A total of 64 consecutive CEAs in 60 patients operated under LA during an 18-month period were prospectively evaluated. The cerebral oximeter was used to measure cerebral oxygen saturation (rSO2) before and after cross-clamping along with serum concentration of S100B protein. Selective shunting was performed when neurological changes occurred, regardless of NIRS. Results: The neurological symptoms that occurred after clamping correlated with an increase in the serum level of S100B (P =.040). The cut-off of 22.5% of S100B increase was determined to be optimal for identifying patients with neurological symptoms. There was no correlation between rSO2 decline and neurological symptoms (P =.675). Two (3.1%) perioperative strokes occurred. Conclusions: Awake neuromonitoring has been found to provide a sensitive and direct evaluation of brain tissue perfusion and is specific to CEA under LA. Although there was a favorable connection between CEA and an increase in serum S100B protein, due to the long assessment time, serum S100B monitoring was not practicable (usually 3 hours).
| Published in | Clinical Medicine Research (Volume 11, Issue 6) |
| DOI | 10.11648/j.cmr.20221106.13 |
| Page(s) | 163-171 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2022. Published by Science Publishing Group |
Perioperative Stroke Prevention, Neuromonitoring, Carotid Stenosis, Selective Shunting
| [1] | Williams IM, Mead G, Picton AJ, Farrell A, Mortimer AJ, McCollum CN. The influence of contralateral carotid stenosis and occlusion on cerebral oxygen saturation during carotid artery surgery. Eur J Vasc Endovasc Surg. 1995; 10 (2): 198–206. |
| [2] | Salvian AJ, Taylor DC, Hsiang YN, Hildebrand HD, Litherland HK, Humer MF, et al. Selective shunting with EEG monitoring is safer than routine shunting for carotid endarterectomy. Cardiovasc Surg. 1997; 5 (5): 481–5. |
| [3] | Beese U, Langer H, Lang W, Dinkel M. Comparison of nearinfrared spectroscopy and somatosensory evoked potentials for the detection of cerebral ischemia during carotid endarterectomy. Stroke. 1998; 29 (10): 2032–7. |
| [4] | Aleksic M, Heckenkamp J, Reichert V, Gawenda M, Brunkwall J. S-100B release during carotid endarterectomy under local anesthesia. Ann Vasc Surg. 2007; 21 (5): 571–5. |
| [5] | Skitek M, Jerin A. Proenkefalin A and protachykinin in ischemic neurological complications after cardiac surgery. Med Glas (Zenica). 2016; 13 (1): 8–13. |
| [6] | Korfias S, Stranjalis G, Papadimitriou A, Psachoulia C, Daskalakis G, Antsaklis A, et al. Serum S-100B protein as a biochemical marker of brain injury: a review of current concepts. Curr Med Chem. 2006; 13: 3719–31. |
| [7] | Arfvidsson B, Nilsson TK, Norgren L. S100B concentrations increase perioperatively in jugular vein blood despite limited metabolic and inflammatory response to clinically uneventful carotid endarterectomy. Clin Chem Lab Med. 2015; 53: 111e7. |
| [8] | Capoccia L, Sbarigia E, Rizzo A, Mansour W, Speziale F. Silent stroke and cognitive decline in asymptomatic carotid stenosis revascularization. Vascular. 2012; 20: 181e7. |
| [9] | Brightwell RE, Sherwood RA, Athanasiou T, Hamady M, Cheshire NJ. The neurological morbidity of carotid revascularisation: using markers of cellular brain injury to compare CEA and CAS. Eur J Vasc Endovasc Surg. 2007; 34: 552–60. |
| [10] | Dragas M, Koncar I, Opacic D, Ilic N, Maksimovic Z, Markovic M, et al. Fluctuations of serum neuron specific enolase and protein S-100B concentrations in relation to the use of shunt during carotid endarterectomy. PLoS One. 2015; 10 (4): e0124067. doi: 10.1371/journal.pone.0124067. eCollection |
| [11] | Capoccia L, Speziale F, Gazzetti M, Mariani P, Rizzo A, Mansour W, et al. Comparative study on carotid revascularization (endarterectomy vs stenting) using markers of cellular brain injury, neuropsychometric tests, and diffusion-weighted magnetic resonance imaging. J Vasc Surg. 2010; 51 (3): 584–91. |
| [12] | Sahlein DH, Heyer EJ, Rampersad A, Winfree CJ, Solomon RA, Benvenisty AI, et al. Failure of intraoperative jugular bulb S-100B and neuron-specific enolase sampling to predict cognitive injury after carotid endarterectomy. Neurosurgery. 2003; 53 (6): 1243–9. |
| [13] | Connolly ES Jr, Winfree CJ, Rampersad A, Sharma R, Mack WJ, Mocco J, et al. Serum S100B protein levels are correlated with subclinical neurocognitive declines after carotid endarterectomy. Neurosurgery. 2001; 49 (5): 1076–82. |
| [14] | Alserr AH, Elwan H, Antonopoulos CN, Abdelreheem A, Elmahdy H, Sayed A, et al. Using serum s100-β protein as a biomarker for comparing silent brain injury in carotid endarterectomy and carotid artery stenting. Int Angiol. 2019; 38 (2): 136–42. |
| [15] | Kuzhuget R, Starodubtsev V, Ignatenko P, Starodubtseva A, Voroshilina O, Ruzankin P, et al. The role of stump pressure and cerebral oximetry in predicting ischaemic brain damage during carotid endarterectomy. Brain Inj. 2017; 31 (13–14): 1944–50. |
| [16] | Ge YL, Li X, Gao JU, Zhang X, Fang X, Zhou L, et al. Beneficial effects of intravenous dexmedetomidine on cognitive function and cerebral injury following a carotid endarterectomy. Exp Ther Med. 2016; 11 (3): 1128–34. |
| [17] | Nagy B, Woth G, Mérei Á, Nagy L, Lantos J, Menyhei G, et al. Perioperative time course of matrix metalloproteinase-9 (MMP-9), its tissue inhibitor TIMP-1 & S100B protein in carotid surgery. Indian J Med Res. 2016; 143 (2): 220–6. |
| [18] | Falkensammer J, Oldenburg WA, Hendrzak AJ, Neuhauser B, Pedraza O, Ferman T, et al. Evaluation of subclinical cerebral injury and neuropsychologic function in patients undergoing carotid endarterectomy. Ann Vasc Surg. 2008; 22 (4): 497–504. |
| [19] | Manwaring ML, Durham CA, McNally MM, Agle SC, Parker FM, Stoner MC. Correlation of cerebral oximetry with internal carotid artery stump pressures in carotid endarterectomy. Vasc Endovascular Surg. 2010; 44 (4): 252–6. |
| [20] | Samra SK, Dorje P, Zelenock GB, Stanley JC. Cerebral oximetry in patients undergoing carotid endarterectomy under regional anesthesia. Stroke. 1996; 27 (1): 49–55. |
| [21] | Al-Rawi PG, Kirkpatrick PJ. Tissue oxygen index: thresholds for cerebral ischemia using near-infrared spectroscopy. Stroke. 2006; 37 (11): 2720–5. |
| [22] | Mille T, Tachimiri ME, Klersy C, Ticozzelli G, Bellinzona G, Blangetti I, et al. Near infrared spectroscopy monitoring during carotid endarterectomy: which threshold value is critical? Eur J Vasc Endovasc Surg. 2004; 27 (6): 646–50. |
| [23] | Kapural M, Krizanac-Bengez LJ, Barnett G, Perl J, Masaryk T, Apollo D, et al. Serum S-100β as a possible marker of bloodbrain barrier disruption. Brain Res. 2002; 940: 102–4. |
| [24] | González-García S, González-Quevedo A, Peña-Sánchez M, Menéndez-Saínz C, Fernández-Carriera R, Arteche-Prior M, et al. Serum neuron-specific enolase and S100 calcium binding protein B biomarker levels do not improve diagnosis of acute stroke. J R Coll Physicians Edinb. 2012; 42 (3): 199–204. |
| [25] | Jickling GC, Sharp FR. Blood biomarkers of ischaemic stroke. Neurotherapeutics. 2011; 8: 349–60. |
| [26] | Dassan P, Keir G, Brown MM. Criteria for a clinically informative serum biomarker in acute ischaemic stroke: a review of S100B. Cerebrovasc Dis. 2009; 27: 295–302. |
| [27] | Hans SS, Jareunpoon O. Prospective evaluation of electroencephalography, carotid artery stump pressure, and neurologic changes during 314 consecutive carotid endarterectomies performed in awake patients. J Vasc Surg. 2007; 45 (3): 511–5. |
| [28] | Evans WE, Hayes JP, Waltke EA, Vermilion BD. Optimal cerebral monitoring during carotid endarterectomy; neurologic response under local anesthesia. J Vasc Surg. 1985; 2: 775–7. |
| [29] | Calligaro KD, Dougherty MJ. Correlation of carotid artery stump pressure and neurological changes during 474 carotid endarterectomies performed in awake patients. J Vasc Surg. 2005; 42: 684–9. |
| [30] | Stroughton J, Nath RL, Abbott WM. Comparison of simultaneous electroencephalographic and mental status monitoring during carotid endarterectomy with regional anesthesia. J Vasc Surg. 1998; 28: 1014–23. |
| [31] | Rockman CB, Riles TS, Gold M, Lamparello PJ, Giangola G, Adelman MA, et al. A comparison of regional and general anesthesia in patients undergoing carotid endarterectomy. J Vasc Surg. 1996; 24: 946–56. |
| [32] | Jaranyi Z, Szekely M, Bobek I, Galfy I, Geller L, Selmeci L. Impairment of blood-brain barrier integrity during carotid surgery as assessed by serum S-100B protein concentrations. Clin Chem Lab Med. 2003; 41: 1320–2. |
| [33] | Duffy CM, Manninen PH, Chan A, Kearns CF. Comparison of cerebral oximeter and evoked potential monitoring in carotid endarterectomy. Can J Anaesth. 1997; 44 (10): 1077–81. |
| [34] | Hernandez-Avila G, Dujovny M, Slavin KV, Luer MS, Nijensohn E, Geremia G, et al. Use of transcranial cerebral oximetry to monitor regional cerebral oxygen saturation during neuroendovascular procedures. AJNR Am J Neuroradiol. 1995; 16 (8): 1618–25. |
| [35] | Duncan LA, Ruckley CV, Wildsmith JA. Cerebral oximetry: a useful monitor during carotid artery surgery. Anaesthesia. 1995; 50 (12): 1041–5. |
| [36] | Lam JM, Smielewski P, al-Rawi P, Griffiths P, Pickard JD, Kirkpatrick PJ. Internal and external carotid contributions to near-infrared spectroscopy during carotid endarterectomy. Stroke. 1997; 28 (5): 906–11. |
| [37] | Jonsson H, Johnsson P, Alling C, Backstrom M, Bergh C, Blomquist S, et al. S100beta after coronary artery surgery: release pattern, source of contamination, and relation to neuropsychometric outcome. Ann Thorac Surg. 1999; 68: 2202–8. |
| [38] | González-Quevedo A, González García S, Fernández Concepción O, et al. Increased serum S-100B and neuron specific enolase potential markers of early nervous system involvement in essential hypertension. Clin Biochem. 2011; 44: 154–9. |
APA Style
Makovec Matej, Mrđa Bozidar, Stirn Barbara. (2022). Biomarker of Cerebral Injury S100 During Carotid Endarterectomy. Clinical Medicine Research, 11(6), 163-171. https://doi.org/10.11648/j.cmr.20221106.13
ACS Style
Makovec Matej; Mrđa Bozidar; Stirn Barbara. Biomarker of Cerebral Injury S100 During Carotid Endarterectomy. Clin. Med. Res. 2022, 11(6), 163-171. doi: 10.11648/j.cmr.20221106.13
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.cmr.20221106.13,
author = {Makovec Matej and Mrđa Bozidar and Stirn Barbara},
title = {Biomarker of Cerebral Injury S100 During Carotid Endarterectomy},
journal = {Clinical Medicine Research},
volume = {11},
number = {6},
pages = {163-171},
doi = {10.11648/j.cmr.20221106.13},
url = {https://doi.org/10.11648/j.cmr.20221106.13},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cmr.20221106.13},
abstract = {Background: The aim of this pilot investigation was to see if a raised serum S100B level or a decrease in rSO2 following carotid revascularization with CEA might be used to detect neurological instability in CEA patients. Increased serum S100B levels during CEA, we hypothesized, would be linked to neurological symptoms after surgery. Patients and methods: A total of 64 consecutive CEAs in 60 patients operated under LA during an 18-month period were prospectively evaluated. The cerebral oximeter was used to measure cerebral oxygen saturation (rSO2) before and after cross-clamping along with serum concentration of S100B protein. Selective shunting was performed when neurological changes occurred, regardless of NIRS. Results: The neurological symptoms that occurred after clamping correlated with an increase in the serum level of S100B (P =.040). The cut-off of 22.5% of S100B increase was determined to be optimal for identifying patients with neurological symptoms. There was no correlation between rSO2 decline and neurological symptoms (P =.675). Two (3.1%) perioperative strokes occurred. Conclusions: Awake neuromonitoring has been found to provide a sensitive and direct evaluation of brain tissue perfusion and is specific to CEA under LA. Although there was a favorable connection between CEA and an increase in serum S100B protein, due to the long assessment time, serum S100B monitoring was not practicable (usually 3 hours).},
year = {2022}
}
TY - JOUR T1 - Biomarker of Cerebral Injury S100 During Carotid Endarterectomy AU - Makovec Matej AU - Mrđa Bozidar AU - Stirn Barbara Y1 - 2022/12/08 PY - 2022 N1 - https://doi.org/10.11648/j.cmr.20221106.13 DO - 10.11648/j.cmr.20221106.13 T2 - Clinical Medicine Research JF - Clinical Medicine Research JO - Clinical Medicine Research SP - 163 EP - 171 PB - Science Publishing Group SN - 2326-9057 UR - https://doi.org/10.11648/j.cmr.20221106.13 AB - Background: The aim of this pilot investigation was to see if a raised serum S100B level or a decrease in rSO2 following carotid revascularization with CEA might be used to detect neurological instability in CEA patients. Increased serum S100B levels during CEA, we hypothesized, would be linked to neurological symptoms after surgery. Patients and methods: A total of 64 consecutive CEAs in 60 patients operated under LA during an 18-month period were prospectively evaluated. The cerebral oximeter was used to measure cerebral oxygen saturation (rSO2) before and after cross-clamping along with serum concentration of S100B protein. Selective shunting was performed when neurological changes occurred, regardless of NIRS. Results: The neurological symptoms that occurred after clamping correlated with an increase in the serum level of S100B (P =.040). The cut-off of 22.5% of S100B increase was determined to be optimal for identifying patients with neurological symptoms. There was no correlation between rSO2 decline and neurological symptoms (P =.675). Two (3.1%) perioperative strokes occurred. Conclusions: Awake neuromonitoring has been found to provide a sensitive and direct evaluation of brain tissue perfusion and is specific to CEA under LA. Although there was a favorable connection between CEA and an increase in serum S100B protein, due to the long assessment time, serum S100B monitoring was not practicable (usually 3 hours). VL - 11 IS - 6 ER -
Email: